Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
Busulfan and Fludarabine in Patients With AML and MDS
ClinicalTrials.gov study NCT00502905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
ClinicalTrials.gov study NCT00656448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MDs on Botox Utility (MOBILITY)
ClinicalTrials.gov study NCT00535938. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00903760. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS
ClinicalTrials.gov study NCT03593915. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS
ClinicalTrials.gov study NCT06020833. IPD Sharing: NO. Countries: 0. Publications: 1.
Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts
ClinicalTrials.gov study NCT03974217. IPD Sharing: YES. Countries: 1. Publications: 0.
A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT00699842. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts
ClinicalTrials.gov study NCT00624585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00071006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
ClinicalTrials.gov study NCT01133275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence
ClinicalTrials.gov study NCT04797000. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission
ClinicalTrials.gov study NCT02302846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00744757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure
ClinicalTrials.gov study NCT01748240. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloi
ClinicalTrials.gov study NCT05796570. IPD Sharing: YES. Countries: 1. Publications: 0.
Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
ClinicalTrials.gov study NCT00334074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib Study for Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00977548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01822691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
ClinicalTrials.gov study NCT02989844. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.